BrightSpring Health Services (NASDAQ:BTSG) Price Target Raised to $25.00

BrightSpring Health Services (NASDAQ:BTSG) had its target price raised by investment analysts at Morgan Stanley from $20.00 to $25.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target suggests a potential upside of 9.55% from the company’s current price.

Other equities research analysts also recently issued reports about the company. Mizuho set a $26.00 price target on BrightSpring Health Services in a research report on Monday, May 5th. UBS Group raised their target price on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. One investment analyst has rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, BrightSpring Health Services currently has an average rating of “Moderate Buy” and an average target price of $22.89.

BrightSpring Health Services Trading Up 1.3 %

Shares of NASDAQ:BTSG opened at $22.82 on Friday. The business has a 50-day moving average price of $17.96 and a 200-day moving average price of $18.72. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of -87.77 and a beta of 2.06. BrightSpring Health Services has a 52-week low of $10.15 and a 52-week high of $24.82. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.10. The company had revenue of $2.88 billion during the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period last year, the firm posted $0.12 EPS. Equities analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.

Institutional Trading of BrightSpring Health Services

A number of institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC grew its stake in BrightSpring Health Services by 21.6% in the 4th quarter. FMR LLC now owns 22,102,490 shares of the company’s stock valued at $376,405,000 after acquiring an additional 3,933,303 shares during the period. T. Rowe Price Investment Management Inc. acquired a new stake in shares of BrightSpring Health Services in the fourth quarter valued at about $26,958,000. Norges Bank purchased a new stake in shares of BrightSpring Health Services during the fourth quarter worth about $26,065,000. Vanguard Group Inc. raised its position in shares of BrightSpring Health Services by 24.6% during the 1st quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company’s stock worth $120,004,000 after purchasing an additional 1,308,651 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in BrightSpring Health Services in the 4th quarter valued at about $18,257,000.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.